Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06761196 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Quality of Life After Breast Cancer Surgery

Study acronym: SOCOM-QoL
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date changed from estimate of Jun 1, 2025 to Sep 2, 2025
    • Primary completion date: Jun 1, 2030 to Sep 1, 2030
    • Study completion date: Jun 1, 2035 to Sep 1, 2035
    v4
  2. Start date: Feb 11, 2025 to Jun 1, 2025
    • Primary completion date: Feb 11, 2030 to Jun 1, 2030
    • Study completion date: Feb 11, 2035 to Jun 1, 2035
    • Eligibility criteria expanded, about 11 words
    v3
  3. Trial status: Not Yet Recruiting to Recruitingv2 Show 8 more changesShow less
    • Primary endpoints: 3 to 1
    • Enrollment target: 2000 to 1500
    • Primary completion date: Feb 1, 2030 to Feb 11, 2030
    • Study completion date: Feb 1, 2035 to Feb 11, 2035
    • Start date changed from estimate of Feb 1, 2025 to Feb 11, 2025
    • Eligibility criteria expanded, about 31 words
    • Secondary endpoints: 2 to 4
    • Site details revised
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to prospectively collect data on quality of life after oncoplastic breast surgery. Participants will be followed-up and answer quality of life questionnaire for a duration of 5 years after surgery.
Trial Details
NCT Number NCT06761196
Lead Sponsor Centre Hospitalier de Colmar
Conditions
(from sponsor)		 Breast Cancer Surgery, Quality of Life
Related terms Breast Neoplasms
Enrollment 1,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov